These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 28951666)

  • 21. Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals in Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia.
    Abdel-Latif MM; Abdel-Wahab BA
    Saudi Pharm J; 2015 Apr; 23(2):154-61. PubMed ID: 25972735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacovigilance and adverse drug reaction reporting: a perspective of community pharmacists and pharmacy technicians in Sana'a, Yemen.
    Al-Worafi YM; Kassab YW; Alseragi WM; Almutairi MS; Ahmed A; Ming LC; Alkhoshaiban AS; Hadi MA
    Ther Clin Risk Manag; 2017; 13():1175-1181. PubMed ID: 28924350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knowledge, Attitude, and Barriers Toward ADRs Reporting Among Health-Care Professionals at Tertiary Care Health Settings in Peshawar, Pakistan: A Web Based Study.
    Ali I; Ahmad W; Ullah AR; Khan F; Ijaz M; Khan S; Khan TM
    Hosp Pharm; 2021 Aug; 56(4):384-391. PubMed ID: 34381279
    [No Abstract]   [Full Text] [Related]  

  • 24. Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon.
    Hajj A; Hallit S; Ramia E; Salameh P;
    Curr Med Res Opin; 2018 Jan; 34(1):149-156. PubMed ID: 28758813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Community pharmacists' challenges regarding adverse drug reaction reporting: a cross-sectional study.
    Paut Kusturica M; Tomas A; Rašković A; Gigov S; Crnobrnja V; Jevtić M; Stilinović N
    Curr Med Res Opin; 2022 Jul; 38(7):1229-1236. PubMed ID: 35470747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse Drug Reaction Monitoring and Reporting Among Physicians and Pharmacists in Pakistan: A Cross-sectional Study.
    Nisa ZU; Zafar A; Zafar F; Pezaro S; Sher F
    Curr Drug Saf; 2020; 15(2):137-146. PubMed ID: 32338223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knowledge, attitudes and practice of nurse regarding adverse drug reaction reporting.
    Hanafi S; Torkamandi H; Hayatshahi A; Gholami K; Javadi M
    Iran J Nurs Midwifery Res; 2012 Jan; 17(1):21-5. PubMed ID: 23492864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of an educational intervention on pharmacovigilance knowledge and attitudes among health professionals in a Nepal cancer hospital.
    Shrestha S; Sharma S; Bhasima R; Kunwor P; Adhikari B; Sapkota B
    BMC Med Educ; 2020 Jun; 20(1):179. PubMed ID: 32493307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain.
    Sweis D; Wong IC
    Drug Saf; 2000 Aug; 23(2):165-72. PubMed ID: 10945377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing knowledge, attitude, and practices of health-care providers toward pharmacovigilance and adverse drug reaction reporting at a comprehensive cancer center in Jordan.
    Al Rabayah AA; Hanoun EM; Al Rumman RH
    Perspect Clin Res; 2019; 10(3):115-120. PubMed ID: 31404206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.
    Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM
    Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring the knowledge, perception, and practice of community pharmacists in Saudi Arabia toward pharmacovigilance and adverse drug reaction reporting. A nationwide survey.
    Khardali A
    Sci Rep; 2024 Feb; 14(1):4819. PubMed ID: 38413787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barriers and facilitators to pharmacovigilance activities in Pakistan: A healthcare professionals-based survey.
    Hussain R; Akram T; Hassali MA; Muneswarao J; Rehman AU; Hashmi F; Babar ZU
    PLoS One; 2022; 17(7):e0271587. PubMed ID: 35905133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China.
    Su C; Ji H; Su Y
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):217-22. PubMed ID: 20033911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knowledge, Attitude and Practice of Hospital Pharmacists in Central China Towards Adverse Drug Reaction Reporting: A Multicenter Cross-Sectional Study.
    Hu W; Tao Y; Lu Y; Gao S; Wang X; Li W; Jiang Q; Lin L; Sun F; Cheng H
    Front Pharmacol; 2022; 13():823944. PubMed ID: 35392558
    [No Abstract]   [Full Text] [Related]  

  • 36. Health-care Professionals' Knowledge and Perception of Adverse Drug Reaction Reporting and Pharmacovigilance in a Tertiary Care Teaching Hospital of Nepal.
    Danekhu K; Shrestha S; Aryal S; Shankar PR
    Hosp Pharm; 2021 Jun; 56(3):178-186. PubMed ID: 34024926
    [No Abstract]   [Full Text] [Related]  

  • 37. Knowledge, attitude and practices toward pharmacovigilance and adverse drug reactions in postgraduate students of Tertiary Care Hospital in Gujarat.
    Upadhyaya HB; Vora MB; Nagar JG; Patel PB
    J Adv Pharm Technol Res; 2015; 6(1):29-34. PubMed ID: 25709967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knowledge, attitudes and practices of nurses and pharmacists towards adverse drug reaction reporting in the South African private hospital sector.
    Bogolubova S; Padayachee N; Schellack N
    Health SA; 2018; 23():1064. PubMed ID: 31934371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacist's knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process.
    Suyagh M; Farah D; Abu Farha R
    Saudi Pharm J; 2015 Apr; 23(2):147-53. PubMed ID: 25972734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacist's Knowledge and Behaviors Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process in Türkiye.
    Albayrak A; Karahalil B
    Turk J Pharm Sci; 2022 Dec; 19(6):694-700. PubMed ID: 36544389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.